192 related articles for article (PubMed ID: 31678773)
1. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
[TBL] [Abstract][Full Text] [Related]
2. A collection of integration-free iPSCs derived from Parkinson's disease patients carrying mutations in the GBA1 gene.
Rodríguez-Traver E; Díaz-Guerra E; Rodríguez C; Fernández P; Arenas F; Araúzo-Bravo M; Orera M; Kulisevsky J; Moratalla R; Vicario C
Stem Cell Res; 2019 Jul; 38():101482. PubMed ID: 31203165
[TBL] [Abstract][Full Text] [Related]
3. UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease.
Braunstein H; Maor G; Chicco G; Filocamo M; Zimran A; Horowitz M
Blood Cells Mol Dis; 2018 Feb; 68():21-29. PubMed ID: 27856178
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition.
Panicker LM; Srikanth MP; Castro-Gomes T; Miller D; Andrews NW; Feldman RA
Hum Mol Genet; 2018 Mar; 27(5):811-822. PubMed ID: 29301038
[TBL] [Abstract][Full Text] [Related]
5. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
Yildiz Y; Hoffmann P; Vom Dahl S; Breiden B; Sandhoff R; Niederau C; Horwitz M; Karlsson S; Filocamo M; Elstein D; Beck M; Sandhoff K; Mengel E; Gonzalez MC; Nöthen MM; Sidransky E; Zimran A; Mattheisen M
Orphanet J Rare Dis; 2013 Sep; 8():151. PubMed ID: 24070122
[TBL] [Abstract][Full Text] [Related]
6. Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations.
Tofoli FA; Chien HF; Barbosa ER; Pereira LV
Stem Cell Res; 2019 Aug; 39():101519. PubMed ID: 31401455
[TBL] [Abstract][Full Text] [Related]
7. Generation of two iPSC lines derived from two unrelated patients with Gaucher disease.
Nagel M; Reichbauer J; Böhringer J; Schelling Y; Krägeloh-Mann I; Schüle R; Ulmer U
Stem Cell Res; 2019 Mar; 35():101336. PubMed ID: 30606667
[TBL] [Abstract][Full Text] [Related]
8. Establishment of MUi030-A: A human induced pluripotent stem cell line carrying homozygous L444P mutation in the GBA1 gene to study type-3 Gaucher disease.
Kangboonruang K; Pornsukjantra T; Tong-Ngam P; Chokpanuwat T; Tim-Aroon T; Wattanasirichaigoon D; Anurathapan U; Hongeng S; Asavapanumas N; Bhukhai K; Tubsuwan A
Stem Cell Res; 2023 Dec; 73():103229. PubMed ID: 37890332
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cellular cobalamin metabolism in Gaucher disease.
Basgalupp SP; Siebert M; Ferreira C; Behringer S; Spiekerkoetter U; Hannibal L; Schwartz IVD
BMC Med Genet; 2020 Jan; 21(1):12. PubMed ID: 31931749
[TBL] [Abstract][Full Text] [Related]
10. Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.
Sun Y; Florer J; Mayhew CN; Jia Z; Zhao Z; Xu K; Ran H; Liou B; Zhang W; Setchell KD; Gu J; Grabowski GA
PLoS One; 2015; 10(3):e0118771. PubMed ID: 25822147
[TBL] [Abstract][Full Text] [Related]
11. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 Editing for Gaucher Disease Modelling.
Pavan E; Ormazabal M; Peruzzo P; Vaena E; Rozenfeld P; Dardis A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380730
[TBL] [Abstract][Full Text] [Related]
13. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
[TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase and its relevance to Parkinson disease.
Do J; McKinney C; Sharma P; Sidransky E
Mol Neurodegener; 2019 Aug; 14(1):36. PubMed ID: 31464647
[TBL] [Abstract][Full Text] [Related]
15. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.
Awad O; Sarkar C; Panicker LM; Miller D; Zeng X; Sgambato JA; Lipinski MM; Feldman RA
Hum Mol Genet; 2015 Oct; 24(20):5775-88. PubMed ID: 26220978
[TBL] [Abstract][Full Text] [Related]
16. Validation of anti-glucocerebrosidase antibodies for western blot analysis on protein lysates of murine and human cells.
Qi W; Davidson BA; Nguyen M; Lindstrom T; Grey RJ; Burnett R; Aflaki E; Sidransky E; Westbroek W
Biochem J; 2019 Jan; 476(2):261-274. PubMed ID: 30578288
[TBL] [Abstract][Full Text] [Related]
17. A generation of human induced pluripotent stem cell line (MUi031-A) from a type-3 Gaucher disease patient carrying homozygous mutation on GBA1 gene.
Pornsukjantra T; Kangboonruang K; Tong-Ngam P; Tim-Aroon T; Wattanasirichaigoon D; Anurathapan U; Hongeng S; Tubsuwan A; Bhukhai K; Asavapanumas N
Stem Cell Res; 2022 Apr; 60():102698. PubMed ID: 35151019
[TBL] [Abstract][Full Text] [Related]
18. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
[TBL] [Abstract][Full Text] [Related]
19. Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes.
Burke DG; Rahim AA; Waddington SN; Karlsson S; Enquist I; Bhatia K; Mehta A; Vellodi A; Heales S
J Inherit Metab Dis; 2013 Sep; 36(5):869-72. PubMed ID: 23151684
[TBL] [Abstract][Full Text] [Related]
20. Two novel mutations in glucocerebrosidase, C23W and IVS7-1 G>A, identified in Type 1 Gaucher patients heterozygous for N370S.
Jack A; Amato D; Morris G; Choy FY
Gene; 2014 Mar; 538(1):84-7. PubMed ID: 24434810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
